Sabra Healthcare Reit Stock Today

SBRA Stock  USD 13.70  0.08  0.58%   

Performance

4 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 9

 
High
 
Low
Low
Sabra Healthcare is trading at 13.70 as of the 25th of April 2024, a -0.58 percent down since the beginning of the trading day. The stock's open price was 13.78. Sabra Healthcare has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Sabra Healthcare REIT are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain
Equity Real Estate Investment Trusts (REITs)
IPO Date
2nd of April 2002
Category
Real Estate
As of March 31, 2022, Sabras investment portfolio included 416 real estate properties held for investment. As of March 31, 2022, Sabras real estate properties held for investment included 41,445 bedsunits, spread across the United States and Canada. Sabra REIT operates under REITHealthcare Facilities classification in the United States and is traded on NASDAQ Exchange. The company has 231.48 M outstanding shares of which 11.19 M shares are at this time shorted by private and institutional investors with about 5.51 trading days to cover. More on Sabra Healthcare REIT

Moving together with Sabra Stock

  0.79IRM Iron Mountain rporated Earnings Call This WeekPairCorr

Moving against Sabra Stock

  0.72HR Healthcare Realty Trust Financial Report 14th of May 2024 PairCorr
  0.67KW Kennedy Wilson Holdings Financial Report 1st of May 2024 PairCorr
  0.44EPR EPR Properties Earnings Call This WeekPairCorr
  0.42UK Ucommune InternationalPairCorr

Sabra Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sabra Healthcare's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sabra Healthcare or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman, CEO and PresRichard Matros
Business ConcentrationDiversified REITs, Equity Real Estate Investment Trusts (REITs), Real Estate, NASDAQ Composite, SP Midcap 400, NASDAQ Composite Total, Real Estate, Diversified REITs, REIT—Healthcare Facilities, Real Estate (View all Sectors)
Average Analyst Recommendation
Analysts covering Sabra Healthcare report their recommendations after researching Sabra Healthcare's financial statements, talking to executives and customers, or listening in on Sabra Healthcare's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Sabra Healthcare REIT. The Sabra consensus assessment is calculated by taking the average forecast from all of the analysts covering Sabra Healthcare.
Financial Strength
Based on the measurements of operating efficiency obtained from Sabra Healthcare's historical financial statements, Sabra Healthcare REIT is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Sabra Healthcare REIT is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.07650.1218
Way Down
Pretty Stable
Gross Profit Margin0.40.4231
Notably Down
Slightly volatile
Net Debt1.9 B2.4 B
Significantly Down
Slightly volatile
Total Current Liabilities243 M231.4 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total1.9 B2.4 B
Significantly Down
Slightly volatile
Total Assets4.2 B5.4 B
Significantly Down
Slightly volatile
Total Current Assets413.9 M543.3 M
Way Down
Slightly volatile
Total Cash From Operating Activities215.7 M301.1 M
Way Down
Slightly volatile
Sabra Healthcare's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Sabra Healthcare's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Sabra Healthcare's financial leverage. It provides some insight into what part of Sabra Healthcare's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Sabra Healthcare's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Sabra Healthcare deploys its capital and how much of that capital is borrowed.
Liquidity
Sabra Healthcare cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 2.45 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Sabra Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Sabra Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sabra Healthcare REIT sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sabra to invest in growth at high rates of return. When we think about Sabra Healthcare's use of debt, we should always consider it together with cash and equity.

Change In Cash

(6.85 Million)
Sabra Healthcare REIT (SBRA) is traded on NASDAQ Exchange in USA. It is located in 1781 Flight Way, Tustin, CA, United States, 92782-0539 and employs 48 people. Sabra Healthcare is listed under Diversified REITs category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.19 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sabra Healthcare's market, we take the total number of its shares issued and multiply it by Sabra Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sabra Healthcare REIT conducts business under Diversified REITs sector and is part of Real Estate industry. The entity has 231.48 M outstanding shares of which 11.19 M shares are at this time shorted by private and institutional investors with about 5.51 trading days to cover. Sabra Healthcare REIT currently holds about 49.05 M in cash with 301.12 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.21.
Check Sabra Healthcare Probability Of Bankruptcy
Ownership Allocation
Sabra Healthcare maintains a total of 231.48 Million outstanding shares. The majority of Sabra Healthcare REIT outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Sabra Healthcare to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Sabra Healthcare REIT. Please pay attention to any change in the institutional holdings of Sabra Healthcare REIT as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Sabra Ownership Details

Sabra Stock Price Odds Analysis

What are Sabra Healthcare's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Sabra Healthcare jumping above the current price in 90 days from now is about 57.35%. The Sabra Healthcare REIT probability density function shows the probability of Sabra Healthcare stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.1088. This usually implies Sabra Healthcare REIT market returns are sensitive to returns on the market. As the market goes up or down, Sabra Healthcare is expected to follow. Additionally, sabra Healthcare REIT has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 13.7HorizonTargetOdds Above 13.7
42.36%90 days
 13.70 
57.35%
Based on a normal probability distribution, the odds of Sabra Healthcare to move above the current price in 90 days from now is about 57.35 (This Sabra Healthcare REIT probability density function shows the probability of Sabra Stock to fall within a particular range of prices over 90 days) .

Sabra Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Sabra Healthcare that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Sabra Healthcare's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sabra Healthcare's value.
InstituionRecorded OnShares
Deutsche Bank Ag2023-12-31
3.6 M
Dimensional Fund Advisors, Inc.2023-12-31
3.2 M
Bank Of America Corp2023-12-31
2.8 M
Goldman Sachs Group Inc2023-12-31
2.3 M
Norges Bank2023-12-31
2.2 M
Nuveen Asset Management, Llc2023-12-31
2.2 M
Duff & Phelps Inv Mgmt Co (il)2023-12-31
2.1 M
Systematic Financial Management Lp2023-12-31
M
Morgan Stanley - Brokerage Accounts2023-12-31
M
Blackrock Inc2023-12-31
34.5 M
Vanguard Group Inc2023-12-31
34.1 M
View Sabra Healthcare Diagnostics

Sabra Healthcare Historical Income Statement

Sabra Healthcare REIT Income Statement is one of the three primary financial statements used for reporting Sabra's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Sabra Healthcare REIT revenue and expense. Sabra Healthcare Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Sabra Healthcare's Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Cost Of Revenue is expected to grow to about 397.2 M, whereas Depreciation And Amortization is forecasted to decline to about 116.9 M. View More Fundamentals

Sabra Stock Against Markets

Picking the right benchmark for Sabra Healthcare stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Sabra Healthcare stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Sabra Healthcare is critical whether you are bullish or bearish towards Sabra Healthcare REIT at a given time. Please also check how Sabra Healthcare's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Sabra Healthcare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

Sabra Healthcare Corporate Directors

Sabra Healthcare corporate directors refer to members of a Sabra Healthcare board of directors. The board of directors generally takes responsibility for the Sabra Healthcare's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Sabra Healthcare's board members must vote for the resolution. The Sabra Healthcare board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Milton WaltersIndependent DirectorProfile
Lynne KatzmannDirectorProfile
Jeffrey MalehornIndependent DirectorProfile
Raymond LewisIndependent DirectorProfile

How to buy Sabra Stock?

Before investing in Sabra Healthcare, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Sabra Healthcare. To buy Sabra Healthcare stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Sabra Healthcare. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Sabra Healthcare stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Sabra Healthcare REIT stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Sabra Healthcare REIT stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Sabra Healthcare REIT, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Sabra Stock please use our How to Invest in Sabra Healthcare guide.

Already Invested in Sabra Healthcare REIT?

The danger of trading Sabra Healthcare REIT is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Sabra Healthcare is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Sabra Healthcare. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Sabra Healthcare REIT is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Sabra Stock analysis

When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Directory
Find actively traded commodities issued by global exchanges
Is Sabra Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.286
Dividend Share
1.2
Earnings Share
0.06
Revenue Per Share
2.788
Quarterly Revenue Growth
0.933
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.